Sign In
Buy IMMU
$87.86
+0 (+0%)
At Close: May 27, 2022
Biotech Bonanza - Second Half Outlook
08:24am, Tuesday, 28'th Jul 2020
Biotech is one of the rare industries whose prospects have improved as the year has progressed. A low interest rate environment, a less hostile regulatory environment, and strong investor interest cre
AstraZeneca Inks Multibillion-Dollar Cancer Treatment Collaboration
08:10pm, Monday, 27'th Jul 2020
AstraZeneca on Monday unveiled a cancer treatment partnership with a Japanese company that could be worth as much as $6 billion and aims for best-in-class treatment of lung and other cancer.
Immunomedics Analyst Says Trodelvy Likely To Capture 50% Market Share
06:23pm, Monday, 27'th Jul 2020
Immunomedics, Inc. (NASDAQ: IMMU) stock, which has been on a broader upward trajectory since FDA approved its lead asset Trodelvy, has further room to run, according to a Jefferies analyst. The Immuno
Read This Before Selling Immunomedics, Inc. (NASDAQ:IMMU) Shares
05:41pm, Monday, 27'th Jul 2020
We often see insiders buying up shares in companies that perform well over the long term. Unfortunately, there are...
Immunomedics to Report Second Quarter 2020 Results and Host Conference Call and Webcast on August 5, 2020
12:00pm, Monday, 27'th Jul 2020
MORRIS PLAINS, N.J., July 27, 2020 (GLOBE NEWSWIRE) -- Immunomedics, Inc. (NASDAQ: IMMU) (“Immunomedics” or the “Company”), a leading biopharmaceutical company in the area of antibody-drug con
AstraZeneca bets up to $6 billion on new Daiichi cancer drug
12:00am, Monday, 27'th Jul 2020
AstraZeneca bets up to $6 billion on new Daiichi cancer drug
Daiichi Sankyo and Gustave Roussy Enter Innovative Research Collaboration for DXd ADCs DS-1062 and Patritumab Deruxtecan
12:00am, Wednesday, 22'nd Jul 2020
Daiichi Sankyo and Gustave Roussy enter innovative research collaboration for DXd ADCs DS-1062 and patritumab deruxtecan (U3-1402).
Advanced Micro Devices, Under Armour, Immunomedics, GenMark and Co-Diagnostics highlighted as Zacks Bull and Bear of the Day
03:16pm, Friday, 17'th Jul 2020
Advanced Micro Devices, Under Armour, Immunomedics, GenMark and Co-Diagnostics highlighted as Zacks Bull and Bear of the Day
Morgan Stanley Has $4.33 Million Position in Immunomedics, Inc. (NASDAQ:IMMU)
04:26am, Thursday, 16'th Jul 2020
Morgan Stanley lowered its stake in shares of Immunomedics, Inc. (NASDAQ:IMMU) by 53.4% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commissi
HC Wainwright Reaffirms “Buy” Rating for Immunomedics (NASDAQ:IMMU)
06:34pm, Wednesday, 15'th Jul 2020
Immunomedics (NASDAQ:IMMU)‘s stock had its “buy” rating reissued by research analysts at HC Wainwright in a research note issued to investors on Tuesday, TipRanks reports. They currently have a
Steven Cohen Homes in on Otonomy by Expanding Stake
05:15pm, Wednesday, 15'th Jul 2020
Guru ups bet in biotech focused on ear-related disorders Continue reading...
Immunomedics Extends Deal With Roche for Two New Studies
03:00pm, Tuesday, 14'th Jul 2020
Immunomedics (IMMU) extends agreement with Roche to evaluate the combination of Trodelvy and Tecentriq in patients with mUC and mNSCLC.
Government must stop England's children becoming long-term victims of Covid-19 | Jenny Coles
01:01pm, Tuesday, 14'th Jul 2020
The social toll of coronavirus on young people could be devastating unless children’s services get the funding they need
